Assembly Biosciences (ASMB) Tax Provisions (2016 - 2024)

Assembly Biosciences (ASMB) recorded quarterly Tax Provisions of -$76000.0 in Q4 2024, down 118.72% quarter-over-quarter from $406000.0 in Q2 2024, and down 330.3% on a YoY basis from $33000.0 in Q1 2024.

Assembly Biosciences (ASMB) Tax Provisions (2016 - 2024) Analysis & Trends

Assembly Biosciences' Tax Provisions history runs 6 years deep, the most recent figure standing at -$76000.0 for Q4 2024.

  • In Q4 2024, Tax Provisions fell 330.3% year-over-year to -$76000.0; the TTM figure through Dec 2025 stood at -$76000.0 (down 120.94% YoY), while the FY2024 annual figure was $330000.0, up 900.0% from the prior year.
  • Tax Provisions was -$76000.0 for Q4 2024 at Assembly Biosciences, down from $406000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $406000.0 in Q2 2024 to a low of -$76000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -11.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 216,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Assembly Biosciences 418.96 Mn 192.36 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -76,000.00
Jun 30, 2024 406,000.00
Dec 31, 2023 33,000.00
Dec 31, 2019 33,000.00
Sep 30, 2019 -15,000.00
Jun 30, 2019 -11,000.00
Mar 31, 2019 -7,000.00
Dec 31, 2018 1.14 Mn
Sep 30, 2018 -6,000.00
Jun 30, 2018 -34,000.00
Dec 31, 2017 -8.94 Mn
Sep 30, 2017 -35,903.00
Jun 30, 2017 -69,513.00
Dec 31, 2016 -618,000.00